Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion.
about
Abnormal shortened diastolic time length at increasing heart rates in patients with abnormal exercise-induced increase in pulmonary artery pressure.Post-exercise contractility, diastolic function, and pressure: operator-independent sensor-based intelligent monitoring for heart failure telemedicine.Diastolic time - frequency relation in the stress echo lab: filling timing and flow at different heart rates.Potential interests of heart rate lowering drugs.PC-based system for retrospective cardiac and respiratory gating of NMR data.Effects of the two enantiomers, S-16257-2 and S-16260-2, of a new bradycardic agent on guinea-pig isolated cardiac preparations.Comparison of the haemodynamic profiles of elgodipine and nicardipine in the anaesthetized dog.Accuracy of subject-specific prediction of end-systolic time in MRI across a range of RR intervals.Usefulness of the systolic time intervals in cardiovascular clinical cardiologyAnalyzing Systolic-Diastolic Interval Interaction Characteristics in Diabetic Cardiac Autonomic Neuropathy ProgressionDifferent effect of exercise on left ventricular diastolic time and interventricular dyssynchrony in heart failure patients with and without left bundle branch blockThe Effects of Ivabradine on Left Ventricular Synchronization and Tei Index in Patients with Systolic Heart Failure.Beta-blocker administration protocol for prospectively ECG-triggered coronary CT angiography.WEB downloadable software for training in cardiovascular hemodynamics in the (3-D) stress echo lab.Effect of coronary vasodilating drug on myocardial work.The fetal brain sparing response to hypoxia: physiological mechanisms.Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.Prognostic impact of heart rate in elderly with systolic heart failure and concomitant atrial fibrillation.Increased diastolic time fraction as beneficial adjunct of alpha1-adrenergic receptor blockade after percutaneous coronary intervention.Model prediction of subendocardial perfusion of the coronary circulation in the presence of an epicardial coronary artery stenosis.Image-based coronary tracking and beat-to-beat motion compensation: feasibility for improving coronary MR angiography.Beta blocking agents: current status in the prevention of sudden coronary death.Myocardial ischaemia. Dilemma between information available and information demand.Diastolic time fraction as a determinant of subendocardial perfusion.Arnold M. Weissler, MD, FACC, FRSM.Early postoperative myocardial morbidity in patients with coronary artery disease undergoing major non-cardiac surgery: correlation with perioperative ischaemia.Effect of lignocaine on coronary blood flow, systolic myocardial function and myocardial high energy phosphate stores in swine.Acute effect of lidocaine on coronary blood flow and myocardial function.Implications for anaesthesia of new concepts in cardiovascular diseases: discussion paper.Screening for coronary artery disease in respiratory patients: comparison of single- and dual-source CT in patients with a heart rate above 70 bpm.Subendocardial viability index is related to the diastolic/systolic time ratio and left ventricular filling pressure, not to aortic pressure: an invasive study in resting humans.Acoustic cardiographic indices of transmyocardial ischemia during percutaneous coronary intervention
P2860
Q30471115-99E04DC4-5DD4-4F46-9D26-D531EB68C9FDQ30489251-8AF53554-AE89-4DAD-A213-B2C8882CC818Q30494520-D65A25AD-743B-48EA-8D84-60F6419B6E6AQ33545059-21DB495B-F657-47AB-9B15-2040C129681DQ34293454-1B30DA16-3ADC-4A61-B95D-58CFD7F0B4FBQ35872243-0945921D-BEF3-4AB6-8882-4F558156E640Q35874280-26DC65AC-7557-4A8B-9C5D-D80AB5F928DCQ36396897-3B09B034-ECDC-4E01-88D7-011B884D0BBBQ36518629-83A09779-F681-47DF-A446-3581DB39BF66Q36844648-BA10726A-8FD8-4FB8-8FA1-312E6C6DA1A1Q36969173-F71A37CF-12AF-4F06-97F2-6D237ED83592Q37590773-0A88CDAA-4794-4FFD-B550-1FD62EF4E7D0Q38175995-CF85D205-5A94-4DD8-8D19-6B1F155C8941Q38426464-DD60DD8D-6EC6-456E-9D34-6392E3632431Q38578757-65453A18-27E5-44AD-B29A-1C193598A081Q38614901-72EC180A-F6C0-4B05-9F3B-1807093B72D6Q38697074-879C2650-0CD7-4ED6-BB2A-055DB0F3971EQ38844930-C857C5AC-734F-43B8-A509-40CD151941A5Q39314521-B5C0BF54-8F99-423E-B8B8-706A3728573CQ39627165-5EFC7BB3-E7AE-49CF-8B54-47ACABF4FA56Q40055235-C63E98A2-90DD-4EED-B534-BBB9EEFFEF46Q40086942-A5283886-63E7-4BFE-8DDF-5E0465F1AC74Q41303749-439B4828-A725-4922-BB88-8CA8CEA98B32Q45199026-2D632494-D658-429A-8AE9-3311C6217E07Q48487977-6EC2F393-27F3-49E2-B08C-7C9EB165A01AQ51703780-F00FF2B4-5EFA-45A9-BDAC-8361B5BAB8E7Q51725803-B6FAD1BD-BD57-40B9-AF24-9CAFE71E3113Q51741823-7E956B66-A8DC-4609-9B42-394653AFE862Q51851955-4E73F63A-3C17-4607-97A2-3D59B4547B94Q53418212-C1B83021-4F58-48C3-A177-1E971369735BQ54503770-45B9A098-FB73-4BD6-83C3-1117CDEC1522Q58270708-CA62DC32-4DE5-47B4-B7F2-CBC08E4EB480
P2860
Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Changes in diastolic time with ...... tion for myocardial perfusion.
@en
type
label
Changes in diastolic time with ...... tion for myocardial perfusion.
@en
prefLabel
Changes in diastolic time with ...... tion for myocardial perfusion.
@en
P2093
P356
P1433
P1476
Changes in diastolic time with ...... tion for myocardial perfusion.
@en
P2093
Boudoulas H
Rittgers SE
Weissler AM
P304
P356
10.1161/01.CIR.60.1.164
P407
P577
1979-07-01T00:00:00Z